Use the following search tool to find news items and information on events. You can narrow down your search by selecting the year and by specifying the category.
The Spanish biotech firm, in which Grifols has a majority shareholding, has presented the first results at the Alzheimer’s Association International Conference in Vancouver (Canada)
Grifols is a company which is committed to encouraging scientific investigation; one of the ways does this is through the Martín Villar Awards for research into haemostasis
The new AMBAR study combines therapeutic plasmapheresis with alternating infusion of albumin and intravenous immunoglobulin (IVIG) to treat Alzheimer’s
Each year, Grifols holds a number of courses intended to provide an opportunity for transfusion medicine professionals to learn and progress. Through training we can ensure the quality and safety of the transfusions that millions of people throughout the world receive each year.
The 72,000-square-foot-facility will create new jobs as well as provide job opportunities for existing Grifols employees through consolidation of the company’s plasma testing operations at the new San Marcos facility and an existing facility in Austin, Texas.
The most significant reductions occur in women with high blood cholesterol (over 240mg/dL), with total cholesterol levels falling by up to 45mg/dL over the following 2 to 4 days.
The information contained on the Grifols worldwide website is not applicable to all countries. For specific information on the products available in your country, please select your country from the list at the top of the page.
